Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De-intensified CRT for HPV+ OPSCC
NCT01530997Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Feb 2012
- Primary completion
- Nov 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Feb 2012; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT01530997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530997.